Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A base editing tool on a lab bench with scientific instruments in a laboratory setting.

Aug 10, 2026

BaseMap ABE Launched for Off-Target Characterization in Base Editing Therapeutic Development

Broken String Biosciences has introduced BaseMap ABE, a novel tool designed to enhance the characterization of off-target effects in adenine base editing (ABE) applications.This launch comes as base editing is increasingly recognized for its ability to facilitate precise genomic alterations. As ABE technologies gain traction in therapeutic settings, there is a growing need for reliable methods to identify and characterize unintended off-target modifications. According to Terry Pizzie, the CEO of
Press release cover image

Aug 10, 2026

Press release

New research explores how data can help detect disease earlier and improve patient care

VANCOUVER, British Columbia, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Every patient has a story, yet no single source of health information tells the whole story. What if researchers could use data to identify multiple sclerosis years before symptoms become apparent? Predict inflammatory bowel disease flare-ups before they occur? Or understand why two patients with similar heart disease have very different outcomes? Genome BC is supporting six new research projects designed to answer these questions.
Flat illustration of a tissue sample and AI system

Aug 10, 2026

Life Sciences AI Technology Benchmark 2026–2027 | Black Book

The 2026-2027 Life Sciences AI Technology Performance Benchmark reveals a significant shift in the expectations of life sciences buyers regarding AI systems.According to a recent report by Black Book Research, in collaboration with Applied Artificial Intelligence LLC, the landscape for AI in life sciences is evolving. The study, based on feedback from over 1,200 verified users across various sectors, assesses 254 market participants within the industry. It highlights that stakeholders are no lon
Press release cover image

Aug 10, 2026

Press release

Novo Nordisk and AWS enter strategic partnership to accelerate drug discovery through AI

New AI co-innovation hub in London brings together AWS engineers, AI specialists, and applied scientists alongside Novo Nordisk research and development teams to increase productivity and help reduce the time to market for future medicines.Agreement establishes AWS as Novo Nordisk's preferred cloud provider and strategic AI partner to accelerate drug discovery and modernise its technology infrastructure, preparing for the next generation of medicines. Bagsværd, Denmark, 10 August, 2026 - Novo No
Press release cover image

Aug 10, 2026

Press release

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

SUNNYVALE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for two new AI algorithm enhancements integrated directly into its existing cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction.1 These new cap
Press release cover image

Aug 10, 2026

Press release

Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology

The collaboration will leverage CrystalO's ion channel small-molecule drug discovery platform and Almirall’s expertise in skin science to jointly advance an innovative small-molecule program in medical dermatology.CrystalO will conduct candidate discovery, optimization, IND-enabling studies and early clinical development to deliver clinical proof of concept (POC), while Almirall will lead subsequent global development, manufacturing and commercialization holding exclusive rights outside mainland
Press release cover image

Aug 10, 2026

Press release

ChemoMetec enters collaboration agreement with Roche Diagnostics

ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming to pursue a collaboration with the goal of creating synergies between the parties’ solutions in the field of bioprocess monitoring, ChemoMetec and Roche Diagnostics have today entered a collaboration agreement. The agreement covers the development of a connection kit between the Roche-owned Cedex® Bio Analyzer and the ChemoMetec-owned Xcytomatic® 30 (XM30) cell counting analyzer, as well as asp
Press release cover image

Aug 9, 2026

Press release

Kyungdong Pharmaceutical and Asimov Announce Completion of Cell Line Development Campaign for Biosimilar Antibody

BOSTON, Aug. 09, 2026 (GLOBE NEWSWIRE) -- Kyungdong Pharmaceutical announced that it has successfully completed a cell line development campaign for a biosimilar antibody candidate, in collaboration with Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development. Through this collaboration, Kyungdong secured a high-performing production cell line for its next-generation biosimilar antibody candidate, laying the foundation for process development, la
A minimalist illustration of a stethoscope and heart rate line representing digital health.

Aug 8, 2026

Lagos Unveils Digital Health Innovation Platform

The Lagos State Government has launched an initiative aimed at revolutionizing healthcare through digital health technologies, artificial intelligence, and collaborative efforts, positioning itself as a leader in medical innovation across Africa.This vision was presented at the Eko Health Convention 2026, where leaders from health, technology, and development sectors gathered to discuss enhancing health outcomes through digital innovations. Prof. Akin Abayomi, the Commissioner for Health, emphas
A test tube with green solution in a lab setting

Aug 8, 2026

Build AI Agents for Life Sciences with NVIDIA BioNeMo and Nebius in partnership with J.P.Morgan

NVIDIA, in collaboration with J.P. Morgan and Nebius, is spearheading a workshop aimed at empowering life sciences professionals to harness AI agents for research and drug development.AI agents are revolutionizing the life sciences landscape by enhancing processes such as literature analysis and drug discovery. The upcoming workshop will focus on the BioNeMo Agent Toolkit, which provides developers and life sciences teams with the tools necessary to create AI-driven workflows across various doma
Minimalist illustration of a brain with data points

Aug 8, 2026

Meet Hemispheric: The Israeli AI startup aiming to revolutionize brain diagnostics

Hemispheric, an innovative AI startup based in Tel Aviv, is poised to transform brain diagnostics with its groundbreaking technology designed to measure and decode human brain activity. The company claims to be the first to offer a precise system that can diagnose various neurological and psychiatric conditions in just 15 minutes, utilizing a unique data collection approach.At the heart of Hemispheric's operations is a substantial database comprising data from over 100,000 subjects, amassing a q
A hand holding a vial of medication in a dimly lit lab setting.

Aug 8, 2026

Johnson & Johnson AI Business Case and Impact

Johnson & Johnson's strategic integration of AI into its promotional review processes exemplifies the transformative potential of technology in the medtech sector.As the medtech industry increasingly embraces artificial intelligence, organizations like Johnson & Johnson are leveraging AI to enhance compliance, accelerate market entry, and boost productivity in promotional reviews. The success of such initiatives hinges on establishing clear key performance indicators (KPIs) and optimizing existi